Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Greenbrook TMS Inc. (T:GTMS)

Business Focus: Hospitals, Clinics & Primary Care Services

Mar 06, 2023 06:00 am ET
GREENBROOK TMS ANNOUNCES RESTRUCTURING PLAN TO REDUCE COSTS, STREAMLINE OPERATIONS AND ACHIEVE PROFITABILITY
TORONTO, March 6, 2023 /CNW/ - Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), announces today that it is embarking on a comprehensive restructuring plan (the "Restructuring Plan") that aims to strengthen the Company by leveraging its scale to further reduce complexity, streamlining its operating model and driving operational efficiencies to achieve profitability.
Feb 27, 2023 08:29 pm ET
Greenbrook to Voluntarily Delist From Toronto Stock Exchange
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), announces that it has applied and received approval for a voluntary delisting of its common shares (each a “Common Share”) from the Toronto Stock Exchange (the “TSX”).
Feb 23, 2023 07:00 am ET
Greenbrook TMS Draws an Additional US$3.0 Million in Debt Financing
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), announces today that it has received an aggregate of US$3.0 million in additional debt financing from its existing lender, Madryn Asset Management, LP (“Madryn”), alongside Greybrook Health Inc. (“Greybrook Health”), one of the Company’s existing significant shareholders to manage the company’s current liquidity requirements. The Company is also currently considering additional near-term financing options to address its future liquidity needs.
Feb 07, 2023 06:00 am ET
GREENBROOK TMS DRAWS AN ADDITIONAL US$2.75 MILLION IN DEBT FINANCING
TORONTO, Feb. 7, 2023 /CNW/ - Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), announces today that it has received an aggregate of US$2.75 million in debt financing from its existing lender, Madryn Asset Management, LP ("Madryn"), alongside certain of the Company's existing significant shareholders and management.
Feb 07, 2023 06:00 am ET
GREENBROOK TMS DRAWS AN ADDITIONAL US$2.75 MILLION IN DEBT FINANCING
TORONTO, Feb. 7, 2023 /PRNewswire/ - Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), announces today that it has received an aggregate of US$2.75 million in debt financing from its existing lender, Madryn Asset Management, LP ("Madryn"), alongside certain of the Company's existing significant shareholders and management.
Nov 08, 2022 05:01 pm ET
Greenbrook TMS Reports Third Quarter Operational and Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its third quarter 2022 (“Q3 2022”) operational and financial results. All values in this press release are in United States dollars, unless otherwise stated.
Oct 26, 2022 05:01 pm ET
Greenbrook TMS Announces Dates for Its Third Quarter 2022 Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its 2022 third quarter operational and financial results after market hours on November 8, 2022.
Aug 02, 2022 05:01 pm ET
Greenbrook TMS Reports Second Quarter Operational and Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its second quarter 2022 (“Q2 2022”) operational and financial results. All values in this press release are in United States dollars, unless otherwise stated.
Jul 27, 2022 05:01 pm ET
Greenbrook TMS Announces Dates for Its Second Quarter 2022 Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its 2022 second quarter operational and financial results after market hours on August 2, 2022.
Jul 14, 2022 05:02 pm ET
Greenbrook TMS Announces Closing of Success TMS Acquisition and US$75 Million Credit Facility With Madryn Asset Management
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce the closing of its previously-announced acquisition (the “Acquisition”) of Check Five LLC, a Delaware limited liability company (doing business as “Success TMS”) (“Success TMS”). In addition, Greenbrook announces today that it and its subsidiaries have entered into a credit agreement for a US$75 million secured credit facility (the “Credit Facility”) with Madr
Jun 27, 2022 05:01 pm ET
Greenbrook TMS Provides an Update on the Success TMS Acquisition
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today an update on the status of its previously-announced proposed acquisition (the “Acquisition”) of Check Five LLC, a Delaware limited liability company (doing business as “Success TMS”) (“Success TMS”). Greenbrook and Success TMS continue to work diligently towards closing the Acquisition and now expect to complete the Acquisition in early Q3 2022.
Jun 21, 2022 05:01 pm ET
Greenbrook TMS Announces Results of Voting at Annual Meeting of Shareholders
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today the results of voting at its annual meeting of shareholders held earlier today (the “Meeting”). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders and Management Information Circular of Greenbrook dated May 11, 2022 (the “Circular”).
Jun 01, 2022 07:00 am ET
Greenbrook TMS to Host Investor Webcast on June 7, 2022
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) is pleased to announce that it will host a webcast investor presentation on Tuesday, June 7th, 2022, at 2:00 PM ET.
May 16, 2022 07:00 am ET
Greenbrook TMS To Acquire Success TMS
Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today that it has entered into a purchase agreement (the “Purchase Agreement”) pursuant to which Greenbrook will acquire Check Five LLC, a Delaware limited liability company (doing business as “Success TMS”) (“Success TMS”).
May 13, 2022 05:01 pm ET
Greenbrook TMS Reports First Quarter Operational and Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its first quarter 2022 (“Q1 2022”) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated.
May 02, 2022 05:01 pm ET
Greenbrook TMS Announces Dates for Its First Quarter 2022 Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its 2022 first quarter operational and financial results after market hours on May 13, 2022.
Apr 11, 2022 08:00 am ET
Greenbrook and Neuronetics Announce Strengthened Commercial Partnership to Build Awareness
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health conditions, and...
Mar 31, 2022 05:05 pm ET
Greenbrook TMS Reports Record Fiscal 2021 Operational and Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its fourth quarter 2021 (“Q4 2021”) and year-end 2021 (“Fiscal 2021”) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated.
Feb 24, 2022 05:00 pm ET
Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2021 Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its 2021 fourth quarter and year end operational and financial results after market hours on March 31, 2022.
Jan 10, 2022 05:00 pm ET
Greenbrook TMS Provides Corporate Update
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”) announced today that Roberto Drassinower will be stepping down from his role as Chief Operating Officer of the Company, effective immediately, but will continue to provide advisory services to the Company pursuant to the terms of a consulting agreement with the Company.
Nov 09, 2021 05:33 pm ET
Greenbrook TMS Reports Third Quarter Operational and Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its third quarter 2021 (“Q3 2021”) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated.
Oct 28, 2021 05:00 pm ET
Greenbrook TMS Announces Dates for Its Third Quarter 2021 Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its third quarter 2021 operational and financial results after market hours on November 9, 2021.
Oct 01, 2021 09:07 am ET
Greenbrook TMS Announces Closing of Achieve TMS East and Central Acquisition
Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce the closing of the acquisition of Achieve TMS East, LLC (“Achieve TMS East”) and Achieve TMS Central, LLC (“Achieve TMS Central”, and together with Achieve TMS East, “Achieve TMS East/Central”).
Sep 27, 2021 08:47 am ET
Greenbrook TMS Completes US$13.2 Million Bought Deal Public Offering
Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce the closing of its previously-announced public offering (the “Offering”). The Offering was made pursuant to an underwriting agreement entered into among Stifel GMP, Bloom Burton Securities Inc. and Lake Street Capital Markets, LLC (collectively, the “Underwriters”).
Sep 22, 2021 10:54 am ET
Greenbrook TMS Announces Increase to Bought Deal Financing to US$11.5 Million
Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce that, due to strong demand, the Company has agreed with a syndicate of underwriters co-led by Stifel GMP and Bloom Burton Securities Inc. (collectively, the “Underwriters”), to increase the size of its previously announced US$10,075,000 (or C$12,909,000) bought deal offering. Pursuant to the upsized deal terms, the Underwriters have agreed to purchase, on a “bought deal” b
Sep 21, 2021 04:56 pm ET
Greenbrook TMS to Acquire Achieve TMS East and Central and Announces US$10 Million Bought Deal Public Offering
Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today that it has entered into a purchase agreement pursuant to which Greenbrook will acquire Achieve TMS East, LLC (“Achieve TMS East”) and Achieve TMS Central, LLC (“Achieve TMS Central”, and together with Achieve TMS East, “Achieve TMS East/Central”).
Sep 21, 2021 04:53 pm ET
IIROC Trading Halt - GTMS
TORONTO, Sept. 21, 2021 /CNW/ - The following issues have been halted by IIROC:
Aug 05, 2021 05:05 pm ET
Greenbrook TMS Reports Second Quarter Operational and Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its second quarter 2021 (“Q2 2021”) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated.
Aug 03, 2021 08:30 am ET
Greenbrook TMS Announces Appointment of Robert Higgins to the Board
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”) is pleased to announce the appointment of Robert Higgins to the board of directors of the Company (the “Board”), effective immediately. The appointment of Mr. Higgins increases the size of the Board to nine members.
Jul 21, 2021 05:00 pm ET
Greenbrook TMS Announces Dates for Its Second Quarter 2021 Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its second quarter 2021 operational and financial results after market hours on August 5, 2021.
Jun 25, 2021 05:15 pm ET
Greenbrook TMS Withdraws Public Offering of Common Shares
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”) today announced that it has elected to withdraw its previously announced public offering of common shares (the “Offering”). In light of market conditions existing at the time the Offering was commenced, and the subsequent completion of the Company’s previously announced US$23.5 million private placement pursuant to Rule 506(c) under the U.S. Securities Act of 1933, the Company has determined to withdraw its short form base PREP prospectus in Canada and its registration statement on Form F-10 in t
Jun 14, 2021 05:05 pm ET
Greenbrook TMS Announces Results of Voting at Annual and Special Meeting of Shareholders
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today the results of voting at its annual and special meeting of shareholders held earlier today (the “Meeting”). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual and Special Meeting of Shareholders and Management Information Circular of Greenbrook dated May 7, 2021 (the “Circular”).
Jun 14, 2021 05:01 pm ET
Greenbrook TMS Announces Completion of US$23.5 Million Private Placement Led by Masters Special Situations
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”) today announced that it has completed a non-brokered private placement (the “Private Placement”) of common shares of the Company (the “Common Shares”). Pursuant to the Private Placement, an aggregate of 2,353,347 Common Shares were issued at a price of US$10.00 per share, for aggregate gross proceeds to the Company of approximately US$23.5 million. The financing was led by new investor Masters Special Situations, LLC and affiliates thereof (“MSS”). In connection with the Private Pla
May 14, 2021 05:01 pm ET
Greenbrook TMS Reports First Quarter Operational and Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its first quarter 2021 (“Q1 2021) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated.
May 13, 2021 05:05 pm ET
Greenbrook TMS Provides Update on Public Offering
Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”) today announced that, due to market conditions, pricing for its previously-announced equity offering (the “Offering”) will be temporarily delayed.
May 07, 2021 08:30 am ET
Greenbrook TMS Announces Change of Dates for Its First Quarter 2021 Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”) announces today that it will postpone the release of its first quarter 2021 operational and financial results, originally scheduled for Wednesday, May 12, 2021. Greenbrook will now release its first quarter 2021 operational and financial results after market hours on Friday, May 14, 2021.
May 04, 2021 04:46 pm ET
Greenbrook TMS Announces Preliminary First Quarter 2021 Operational and Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”) today announced certain preliminary unaudited operational and financial results for the first quarter ended March 31, 2021 (“Q1 2021”). All values in this news release are in United States dollars, unless otherwise stated.
May 04, 2021 04:46 pm ET
Greenbrook TMS Announces Proposed Public Offering of Common Shares
Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (“Greenbrook” or the “Company”) today announces that it is pursuing an underwritten public offering of common shares (the “Common Shares”) in the United States and Canada (the “Offering”). The Common Shares are being offered by Stifel, Canaccord Genuity and BTIG, as joint book-running managers, and by Bloom Burton, as co-manager (collectively, the “Underwriters”).
Apr 20, 2021 05:01 pm ET
Greenbrook TMS Announces Dates for Its First Quarter 2021 Financial Results and Provides Corporate Update
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its first quarter 2021 operational and financial results after market hours on May 12, 2021.
Mar 30, 2021 05:05 pm ET
Greenbrook TMS Reports Fiscal 2020 Operational and Financial Results
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its fourth quarter 2020 (“Q4 2020”) and year-end 2020 (“Fiscal 2020”) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated.
Mar 15, 2021 05:00 pm ET
Greenbrook to Commence Trading on NASDAQ
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) is pleased to announce that its common shares have been approved for listing and trading in U.S. dollar currency on the NASDAQ Stock Market LLC (“NASDAQ”). Trading on the NASDAQ will commence at the start of trading on March 16, 2021 under the symbol “GBNH”. Greenbrook’s common shares will continue trading on the Toronto Stock Exchange in Canadian dollar currency under the symbol “GTMS”.
Feb 23, 2021 05:00 pm ET
Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2020 Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), will release its 2020 fourth quarter and year end operational and financial results after market hours on March 30, 2021.
Feb 01, 2021 05:00 pm ET
Greenbrook TMS Announces Completion of Share Consolidation in Connection With Proposed NASDAQ Listing
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) is pleased to announce that, in conjunction with its application to list its common shares (the “Common Shares”) on The NASDAQ Stock Market LLC (“NASDAQ”), the Company has completed the consolidation of its issued and outstanding Common Shares on the basis of one (1) post-consolidation Common Share for every five (5) pre-consolidation Common Shares (the “Share Consolidation”).
Jan 27, 2021 05:01 pm ET
Greenbrook TMS Included in First Psychedlics-Focused Exchange Traded Fund
Greenbrook TMS Inc. (TSX:GTMS) (“Greenbrook” or the “Company”) is pleased to announce that it is one of seventeen companies in the U.S. and Canada that will be included in the world’s first psychedelics focused exchange traded fund, which is managed by Horizons ETFs Management (Canada) Inc.
Jan 15, 2021 06:00 pm ET
Greenbrook TMS Announces Director Resignation
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) announced today that Mr. Stephan Roker has provided notice of his intention to resign as a director of the Company, effective today, citing the existence of previously unforeseen conflicts of interest as the reason for his resignation.
Jan 12, 2021 05:01 pm ET
Greenbrook TMS Provides Update on Share Consolidation and Appointment of Stephan Roker to the Board
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) is pleased to announce that its shareholders have approved a special resolution for an amendment to the Company’s articles and has authorized a consolidation (the “Share Consolidation”) of the Company’s outstanding common shares (“Common Shares”). The resolution was approved at the special meeting of shareholders held earlier today (the “Special Meeting”).
Dec 31, 2020 09:47 am ET
Greenbrook TMS Closes US$30 Million Credit Facility With Oxford Finance LLC
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today that it and its subsidiaries have entered into a credit and security agreement for a US$30 million secured credit facility (the “Credit Facility”) with Oxford Finance LLC (“Oxford”).
Dec 07, 2020 05:00 pm ET
Greenbrook TMS to Participate at the 13th Annual LD Micro Main Event Conference
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce that Bill Leonard, Chief Executive Officer, will present at the 13th Annual LD Micro Main Event Conference, on December 15, 2020 at 9:40 a.m. (Eastern Time).
Dec 04, 2020 05:05 pm ET
Greenbrook TMS Announces Proposed Share Consolidation
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) announces today that, in support of its previously-announced application to list its common shares (the “Common Shares”) on The Nasdaq Stock Market LLC (“NASDAQ”), and to assist the Company in meeting the NASDAQ’s initial listing requirements, the Company will hold a special meeting of shareholders (the “Special Meeting”) on January 12, 2021 to, among other things, consider, and if deemed appropriate, to approve, a special resolution to authorize amendments of the Company’s articles to con
Nov 18, 2020 05:00 pm ET
Greenbrook TMS Announces Participation in Upcoming Investor Conferences
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce that Bill Leonard, Chief Executive Officer, will participate in two upcoming virtual investor conferences.
Nov 10, 2020 06:33 pm ET
Greenbrook TMS Reports Third Quarter Financial Results With Continued Resilient Performance Through the COVID-19 Pandemic, Announces Spravato® Pilot Program and Provides Corporate Update
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), today announced its third quarter 2020 (“Q3 2020”) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated.
Nov 05, 2020 04:01 pm ET
Greenbrook TMS Announces Submission of Its Application to List on NASDAQ
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce that it has submitted its application to list its common shares (the “Common Shares”) on The Nasdaq Stock Market LLC (“NASDAQ”). In advance of its anticipated listing on NASDAQ, the Company will file a Form 20-F Registration Statement with the United States Securities and Exchange Commission (the “SEC”). The listing of the Company’s Common Shares on NASDAQ remains su
Oct 20, 2020 05:00 pm ET
Greenbrook TMS Announces Dates for Its Third Quarter 2020 Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), will release its third quarter 2020 operational and financial results after market hours on November 10, 2020.
Sep 17, 2020 07:00 am ET
Greenbrook TMS to Host Investor Webcast on September 24, 2020
Greenbrook TMS Inc. (TSX:GTMS) (“Greenbrook” or the “Company”) is pleased to announce that it will host a webcast investor presentation on Thursday, September 24, 2020 at 2:00 PM ET.
Sep 15, 2020 05:00 pm ET
Greenbrook TMS Reaches Milestone with More Than 500,000 Treatments
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, today announced it has delivered more than 500,000 TMS treatments since the Company was founded in 2011.
Aug 31, 2020 05:00 pm ET
LD Micro -- 360 Companies Set to Present this Week
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
Aug 05, 2020 09:00 am ET
LD Micro - Announces Preliminary List of Presenters for the LD-500
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
Aug 04, 2020 08:19 pm ET
Greenbrook TMS Reports Second Quarter Financial Results With Resilient Performance Through the COVID-19 Pandemic
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), today announced its second quarter 2020 (“Q2 2020”) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated.
Jul 21, 2020 05:05 pm ET
Greenbrook TMS Announces Dates for Its Second Quarter 2020 Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), will release its second quarter 2020 operational and financial results after market hours on August 4, 2020.
Jun 29, 2020 05:15 pm ET
Greenbrook TMS Announces Results of Voting at Annual Meeting of Shareholders
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today the results of voting at its annual meeting of shareholders held earlier today (the “Meeting”). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders and Management Information Circular of Greenbrook dated May 19, 2020.
Jun 17, 2020 04:01 pm ET
Greenbrook TMS to Hold Virtual Annual Meeting of Shareholders on June 29
Greenbrook TMS Inc. (“Greenbrook” or the “Company”) (TSX: GTMS) announces that, due to the COVID-19 pandemic, it will hold its Annual Meeting of Shareholders (the “Meeting”) on Monday, June 29, 2020 at 10:00 a.m. (Toronto time) by way of virtual-only meeting via live audio webcast and teleconference. Shareholders will not be able to attend in person at the Meeting.
May 21, 2020 08:59 am ET
Greenbrook TMS Completes C$15 Million Equity Offering
Greenbrook TMS Inc. (“Greenbrook” or the “Company”) (TSX: GTMS) is pleased to announce the closing of its previously announced public offering (the “Offering”) of common shares of the Company (the “Offered Shares”). The Offering was made pursuant to an agency agreement (the “Agency Agreement”) entered into among Bloom Burton Securities Inc. and Clarus Securities Inc., as co-lead agents, Canaccord Genuity Corp., Desjardins Securities Inc. and Stifel GMP (collectively, the “Agents”).
May 12, 2020 09:17 pm ET
Greenbrook TMS Reports First Quarter Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), today announced its first quarter 2020 (“Q1 2020”) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated.
May 06, 2020 10:58 am ET
IIROC Trade Resumption - GTMS
TORONTO, May 6, 2020 /CNW/ - Trading resumes in:
May 06, 2020 10:51 am ET
Greenbrook TMS Announces Pricing of Overnight Marketed Offering of Common Shares
Greenbrook TMS Inc. (“Greenbrook” or the “Company”) (TSX: GTMS) announced today that it has priced its previously announced overnight marketed offering (the “Offering”) of common shares of the Company (the “Offered Shares”). The Company intends to issue a minimum of 8,484,849 Offered Shares and a maximum of 10,909,091 Offered Shares at a price of C$1.65 per Offered Share for gross proceeds of a minimum of approximately C$14,000,000 and a maximum of approximately C$18,000,000.
May 06, 2020 09:33 am ET
IIROC Trading Halt - GTMS
TORONTO, May 6, 2020 /CNW/ - The following issues have been halted by IIROC:
May 05, 2020 04:17 pm ET
Greenbrook TMS Announces Overnight Marketed Offering of Common Shares
Greenbrook TMS Inc. (“Greenbrook” or the “Company”) (TSX: GTMS) announced today that it has filed and been receipted for a preliminary short form prospectus (the “Preliminary Prospectus”) with securities regulatory authorities in the provinces of British Columbia, Alberta, Saskatchewan, Manitoba and Ontario, pursuant to National Instrument 44-101 Short Form Prospectus Distributions, in connection with a proposed overnight marketed offering (the “Offering”) of common shares of the Company (the “Offered Shares”). The Offering is being co-led by Bloom Bur
Apr 30, 2020 05:04 pm ET
Greenbrook TMS Announces Preliminary First Quarter 2020 Results and Provides a Business Update
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) today announced certain preliminary unaudited financial results for the quarter ended March 31, 2020 (“Q1 2020”) and also provided an update regarding the impact of the COVID-19 pandemic on its business, as well as actions taken in response to this unprecedented operating environment.
Apr 23, 2020 05:05 pm ET
Greenbrook TMS Announces Dates for Its First Quarter 2020 Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its first quarter 2020 operational and financial results after market hours on May 12, 2020.
Mar 25, 2020 03:00 pm ET
Greenbrook TMS Provides Update Regarding COVID-19 Response
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) today provides the following update regarding the impact of the COVID-19 pandemic on Greenbrook’s business and its response to dealing with the pandemic.
Mar 10, 2020 08:21 pm ET
Greenbrook TMS Reports Record Fourth Quarter and Year End 2019 Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) today announced its fourth quarter (“Q4 2019”) and year-end 2019 (“Fiscal 2019”) operational and financial results. All values in this press release are in United States dollars, unless otherwise stated.
Feb 04, 2020 07:00 am ET
Greenbrook TMS to Host Investor Webcast on February 11, 2020
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) is pleased to announce that it will host a webcast investor presentation on Tuesday, February 11, 2020 at 11:00 AM ET.
Jan 14, 2020 05:05 pm ET
Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2019 Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its 2019 fourth quarter and year end operational and financial results after market hours on March 10, 2020.
Dec 05, 2019 07:45 am ET
Greenbrook TMS to Participate at 31st Annual Piper Jaffray Healthcare Conference
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), the market leader in Transcranial Magnetic Stimulation (“TMS”) in the United States, is pleased to announce that Bill Leonard, Chief Executive Officer, will present at the 31st Annual Piper Jaffray Healthcare Conference in New York, NY on December 5, 2019 at 11:30 a.m. Eastern Time.
Nov 04, 2019 05:40 pm ET
Greenbrook TMS Reports Record Third Quarter Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) today announced its third quarter 2019 operational and financial results. All values in this news release are in United States dollars, unless otherwise stated.
Oct 08, 2019 05:00 pm ET
Greenbrook TMS Announces Dates for Its Third Quarter 2019 Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its 2019 third quarter operational and financial results after market hours on November 4, 2019.
Sep 26, 2019 09:11 am ET
Greenbrook TMS Announces Closing of Acquisition of Achieve TMS
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) is pleased to announce the closing of the acquisition of Achieve TMS Centers, LLC and Achieve TMS Alaska, LLC (collectively, “Achieve TMS”), as previously announced on September 11, 2019 (the “Acquisition”).
Sep 12, 2019 07:49 am ET
IIROC Trade Resumption - GTMS
TORONTO, Sept. 12, 2019 /CNW/ - Trading resumes in:
Sep 11, 2019 04:57 pm ET
IIROC Trading Halt - GTMS
TORONTO, Sept. 11, 2019 /CNW/ - The following issues have been halted by IIROC:
Sep 11, 2019 04:50 pm ET
Greenbrook TMS to Acquire Achieve TMS
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), the market leader in Transcranial Magnetic Stimulation (“TMS”) in the United States, announced today that it has, through its wholly-owned subsidiary TMS NeuroHealth Centers Inc., entered into a purchase agreement pursuant to which Greenbrook will acquire Achieve TMS Centers, LLC and Achieve TMS Alaska, LLC (collectively, “Achieve TMS”).
Aug 06, 2019 06:01 pm ET
Greenbrook TMS Continues Execution of Growth Strategy and Reports Record Second Quarter Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), today announced its second quarter 2019 operational and financial results. For more information, please refer to the Management’s Discussion & Analysis of Financial Condition and Results of Operations (“MD&A”) and the unaudited condensed interim consolidated financial statements of the Company for the three and six months ended June 30, 2019 and 2018. These documents will be available on the Company’s website at
Jul 09, 2019 04:10 pm ET
Greenbrook TMS Announces Dates for Its Second Quarter 2019 Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its 2019 second quarter operational and financial results after market hours on August 6, 2019.
Jun 28, 2019 05:10 pm ET
Greenbrook TMS Announces Results of Voting at Annual and Special Meeting of Shareholders
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today the results of voting at its annual and special meeting of shareholders held earlier today (the “Meeting”). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual and Special Meeting of Shareholders and Management Information Circular of Greenbrook dated May 24, 2019.
May 17, 2019 08:33 am ET
Greenbrook TMS Completes C$30 Million Bought Deal Public Offering and Concurrent Private Placement
Greenbrook TMS Inc. (TSX:GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today that it has completed its previously announced bought deal public offering and concurrent private placement (the “Offerings”) for total gross proceeds of C$30,579,250.
May 09, 2019 07:19 pm ET
Greenbrook TMS Continues Execution of Growth Strategy and Reports First Quarter Financial Results
Greenbrook TMS Inc. (TSX:GTMS) (“Greenbrook” or the “Company”), today announced its first quarter 2019 operational and financial results. For more information, please refer to Management’s Discussion & Analysis of Financial Condition and Results of Operations (“MD&A”) and the unaudited condensed interim consolidated financial statements of the Company for the three-months ended March 31, 2019 and 2018. These documents will be available on the Company’s website at
May 09, 2019 07:00 pm ET
Greenbrook TMS Announces Expansion into Michigan
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce the expansion of its TMS Center network into the State of Michigan. The Company will begin operating a TMS Center in the Detroit, Michigan region.
Apr 29, 2019 04:29 pm ET
Greenbrook TMS Announces C$29 Million Bought Deal Public Offering and Concurrent Private Placement
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today that it has entered into an agreement with a syndicate of underwriters led by Bloom Burton Securities Inc., and including Clarus Securities Inc., Desjardins Securities Inc. and GMP Securities L.P. (collectively, the “Underwriters”), under which the Underwriters have agreed to buy, on a bought deal public offering basis, 3,500,000 common shares of
Apr 18, 2019 04:10 pm ET
Greenbrook TMS to Present at 2019 Bloom Burton & Co. Healthcare Investor Conference
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce that it will participate and present at the Bloom Burton & Co. Healthcare Conference in Toronto on April 30th to May 1st, 2019.
Apr 09, 2019 04:05 pm ET
Greenbrook TMS Announces Dates for Its First Quarter 2019 Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its 2019 first quarter operational and financial results after market hours on May 9, 2019.
Apr 02, 2019 05:43 pm ET
Greenbrook TMS Selected by Kaiser Permanente as Provider of TMS Therapy Services in the Mid-Atlantic States
Greenbrook TMS Inc. (TSX:GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce that it has entered into an agreement with Kaiser Foundation Health Plan of the Mid-Atlantic States, Inc. (“Kaiser”) pursuant to which Greenbrook and its affiliates will provide TMS therapy services to Kaiser members in Maryland, Virginia and the District of Columbia.
Mar 27, 2019 07:07 pm ET
Greenbrook TMS Reports Fourth Quarter and Year End 2018 Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) today announced its fourth quarter (“Q4 2018”) and year-end 2018 (“Fiscal 2018”) operational and financial results. For more information, please refer to the Company’s audited consolidated financial statements, including the notes thereto, for the fiscal years ended December 31, 2018 and 2017 and related Management’s Discussion & Analysis of Financial Condition and Results of Operations (“MD&A”). These documents will be available on the Company’s w
Feb 26, 2019 08:30 am ET
Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2018 Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its 2018 fourth quarter and year end operational and financial results after market hours on March 27, 2019.
Jan 09, 2019 07:00 am ET
Greenbrook Tms Announces Expansion Into Tampa-St. Petersburg Florida
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce the expansion of its TMS Center network into the Tampa-St....
Dec 28, 2018 04:02 pm ET
Greenbrook TMS Announces Expansion Into Cleveland, Ohio
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce the expansion of its TMS Center network into the Cleveland...
Nov 12, 2018 05:26 pm ET
Greenbrook TMS Continues Successful Execution of Growth Strategy and Reports Third Quarter Financial Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) today announced its third quarter 2018 operational and financial results. For more information, please refer to Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) and the unaudited condensed interim consolidated financial statements for the three- and nine-month periods ended September 30, 2018 and 2017. These documents will be available on the Company's website at
Nov 08, 2018 07:00 am ET
Greenbrook TMS Centers Begin to Treat Obsessive Compulsive Disorder With TMS Therapy
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States for the treatment of Major Depressive Disorder (“MDD”), is pleased to announce that its...
Oct 31, 2018 05:02 pm ET
Greenbrook TMS Announces Expansion Into Houston Texas
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States for the treatment of Major Depressive Disorder (“MDD”), is pleased to announce the...
Oct 29, 2018 04:30 pm ET
Greenbrook TMS Announces Dates for Its Third Quarter 2018 Results
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its third quarter 2018 operational and financial results after market hours on November 12, 2018.
Oct 23, 2018 07:30 am ET
Greenbrook TMS Announces Expansion Into Austin Texas
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States for the treatment of Major Depressive Disorder (“MDD”), is pleased to announce the...
Oct 16, 2018 12:26 pm ET
Greenbrook TMS Announces Expansion Into Connecticut
Greenbrook TMS Inc. (“Greenbrook” or the “Company”) (TSX:GTMS), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States for the treatment of Major Depressive Disorder (“MDD”), is pleased to announce the...
Oct 12, 2018 11:29 am ET
Greenbrook TMS Inc. Opens the Market
TORONTO, Oct. 12, 2018 /CNW/ - Bill Leonard, President and CEO, Greenbrook TMS Inc. (GTMS), joined Michael Kousaie, Vice-President, Strategy and Product Innovation, Toronto Stock Exchange and TSX Venture Exchange, to open the market. Operating through 43 company-operated treatment centers, Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation (TMS), an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder (MDD), in the United States. Since opening their flagship Center in McLean, Virginia in 2011, Greenbrook TMS has provided more than 160,000 treat
Oct 03, 2018 08:20 am ET
IIROC Trade Resumption - GTMS
TORONTO, le 3 oct. 2018 /CNW/ - Trading resumes in:
Oct 03, 2018 08:10 am ET
IIROC Trading Halt - GTMS
TORONTO, Oct. 3, 2018 /CNW/ - The following issues have been halted by IIROC:
Oct 03, 2018 07:00 am ET
Greenbrook TMS Announces Listing on the Toronto Stock Exchange
Greenbrook TMS Inc. (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States for the treatment of Major Depressive Disorder (“MDD”), today announced that the Toronto Stock...
Sep 27, 2018 01:20 pm ET
Greenbrook TMS Announces Filing of Final Prospectus
Greenbrook TMS Inc. (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States for the treatment of Major Depressive Disorder (“MDD”), today announced that it has filed and obtained...